| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The perivascular niche regulates breast tumour dormancy.
|
Nat Cell Biol
|
2013
|
3.36
|
|
2
|
Molecular mechanisms of fibrinolysis.
|
Br J Haematol
|
2005
|
3.03
|
|
3
|
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.
|
J Clin Invest
|
2004
|
2.45
|
|
4
|
An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface.
|
J Biol Chem
|
2004
|
1.68
|
|
5
|
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
|
Blood
|
2013
|
1.48
|
|
6
|
Annexin II: a plasminogen-plasminogen activator co-receptor.
|
Front Biosci
|
2002
|
1.47
|
|
7
|
Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.
|
J Cereb Blood Flow Metab
|
2010
|
1.44
|
|
8
|
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.
|
Blood
|
2006
|
1.34
|
|
9
|
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.
|
Blood
|
2003
|
1.32
|
|
10
|
Annexin A2 promotes glioma cell invasion and tumor progression.
|
J Neurosci
|
2011
|
1.23
|
|
11
|
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
|
J Biol Chem
|
2008
|
1.22
|
|
12
|
The annexin A2 system and vascular homeostasis.
|
Vascul Pharmacol
|
2011
|
1.14
|
|
13
|
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.
|
Blood
|
2009
|
1.13
|
|
14
|
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.
|
J Clin Invest
|
2009
|
1.04
|
|
15
|
Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation.
|
PLoS One
|
2012
|
1.04
|
|
16
|
Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina.
|
Mol Biol Cell
|
2009
|
0.99
|
|
17
|
Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.
|
Gastroenterology
|
2010
|
0.98
|
|
18
|
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.
|
Stroke
|
2010
|
0.98
|
|
19
|
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.
|
J Biol Chem
|
2010
|
0.96
|
|
20
|
Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.
|
Brain Res
|
2007
|
0.96
|
|
21
|
Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis.
|
Stroke
|
2010
|
0.96
|
|
22
|
The annexin A2/S100A10 system in health and disease: emerging paradigms.
|
J Biomed Biotechnol
|
2012
|
0.96
|
|
23
|
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.
|
Blood
|
2011
|
0.92
|
|
24
|
Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization.
|
FASEB J
|
2006
|
0.92
|
|
25
|
Annexin A2 system in human biology: cell surface and beyond.
|
Semin Thromb Hemost
|
2013
|
0.92
|
|
26
|
Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris.
|
Nat Commun
|
2012
|
0.92
|
|
27
|
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
|
J Cell Biochem
|
2003
|
0.90
|
|
28
|
Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart.
|
Dev Biol
|
2004
|
0.90
|
|
29
|
The endothelial cell annexin A2 system and vascular fibrinolysis.
|
Gen Physiol Biophys
|
2009
|
0.88
|
|
30
|
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
|
Cancer
|
2010
|
0.85
|
|
31
|
Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells.
|
J Cell Sci
|
2013
|
0.82
|
|
32
|
Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity.
|
Thromb Haemost
|
2013
|
0.81
|
|
33
|
Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis.
|
Genesis
|
2014
|
0.80
|
|
34
|
Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer.
|
Anticancer Res
|
2002
|
0.79
|
|
35
|
Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.78
|
|
36
|
Aaron J. Marcus: in pursuit of perfection.
|
J Clin Invest
|
2015
|
0.75
|
|
37
|
The annexin A2 system and angiogenesis.
|
Biol Chem
|
2016
|
0.75
|
|
38
|
Corrigendum: Annexin A2 promotes phagophore assembly by enhancing Atg16⁺ vesicle biogenesis and homotypic fusion.
|
Nat Commun
|
2015
|
0.75
|